Immunohistochemical investigations have shown that insulin-like growth factor-I receptor (IGF1R) overexpression is linked to poor prognosis in patients with pancreatic ductal adenocarcinoma [27]. The gene discussed is IGF1R; the disease is pancreatic ductal adenocarcinoma.